MATR3 pathogenic variants differentially impair its cryptic splicing repression function

FEBS Lett. 2024 Feb;598(4):415-436. doi: 10.1002/1873-3468.14806. Epub 2024 Feb 6.

Abstract

Matrin-3 (MATR3) is an RNA-binding protein implicated in neurodegenerative and neurodevelopmental diseases. However, little is known regarding the role of MATR3 in cryptic splicing within the context of functional genes and how disease-associated variants impact this function. We show that loss of MATR3 leads to cryptic exon inclusion in many transcripts. We reveal that ALS-linked S85C pathogenic variant reduces MATR3 solubility but does not impair RNA binding. In parallel, we report a novel neurodevelopmental disease-associated M548T variant, located in the RRM2 domain, which reduces protein solubility and impairs RNA binding and cryptic splicing repression functions of MATR3. Altogether, our research identifies cryptic events within functional genes and demonstrates how disease-associated variants impact MATR3 cryptic splicing repression function.

Keywords: MATR3; RNA-binding protein; amyotrophic lateral sclerosis; cryptic splicing; neurodevelopmental disease.

MeSH terms

  • Amyotrophic Lateral Sclerosis* / genetics
  • Exons / genetics
  • Humans
  • Nuclear Matrix-Associated Proteins / genetics
  • RNA
  • RNA-Binding Proteins / genetics
  • RNA-Binding Proteins / metabolism

Substances

  • RNA-Binding Proteins
  • RNA
  • MATR3 protein, human
  • Nuclear Matrix-Associated Proteins